UCSF

Tagged: nanotechnology

Desai inducted into International Academy of Medical and Biological Engineering

Desai was recognized for being a “pioneer in the use of micro and nanoscale materials to deliver protein and cell-based therapeutics.”

Novel diabetes treatment developed in Desai Lab to power SF-area startup

A UC San Francisco-created, insulin-generating implant that utilizes nanotechnology is closer to becoming a real treatment for diabetes, after being acquired by a San Francisco-based startup.

Prien and MacWilliam bequests establish new endowed professorships

The UCSF School of Pharmacy has established new endowed faculty positions to be held by the chairs of two School departments.

Major funding for The Kidney Project from NIBIB Quantum Program

The research journey toward building a fully functioning, surgically implantable artificial kidney as an alternative to kidney transplant and dialysis just took another step forward with the announcement of a $6 million grant to The Kidney Project, headquartered at the UCSF School of Pharmacy.

Desai elected to the National Academy of Medicine

UCSF School of Pharmacy faculty member Tejal Desai, PhD, has been newly elected to the National Academy of Medicine (NAM), formerly known as the Institute of Medicine (IOM).

Desai Lab develops nanodevices to aid artery repair

Research in the laboratory of Tejal Desai, PhD, is creating new kinds of drug delivery devices to reduce the scarring and inflammation that can undermine stents—metal mesh tubes implanted to prop open blocked arteries, including in the heart.

Tejal Desai, PhD

Professor & Chair

I am a bioengineer focusing on micro and nanofabrication techniques to create new devices for drug and cell delivery as well as biomaterials for cell and tissue regeneration. I also chair the Department of Bioengineering and Therapeutic Sciences.

Shuvo Roy, PhD

Professor

I am a bioengineer working on medical device development to address clinical needs by leveraging my background in MEMS (microelectromechanical systems) along with advances in biomaterials, electronics, and nanotechnology to advance health world-wide.

New NIH funding awarded to the Department of Bioengineering and Therapeutic Sciences in 2011

New research support awarded to the UCSF School of Pharmacy by the National Institutes of Health during the 2011 fiscal year included a half-dozen on-going projects by BTS faculty:

In-flight programming features bioartificial kidney

Passengers who travel on American Airlines from September through October 2011 will learn about the surgically implantable bioartificial kidney being developed at UCSF as a permanent solution to end stage renal disease.

Pages